Blog
RSS FeedPosted by Michael Wonder on 02 Apr 2020
Proposal to fund modified release pancreatic enzyme granules (Creon Micro)
2 April 2020 - PHARMAC is seeking feedback on a proposal to fund a new modified-release granule formulation of pancreatic ...
Posted by Michael Wonder on 28 Oct 2019
‘Let private health funds cover all GP bills’
29 October 2019 - Private health insurers are pushing for reform of the healthcare system to allow them to pay ...
Posted by Michael Wonder on 31 Jul 2019
Patient preferences studies: how NICE aims to make use of them
2 July 2019 - Dr Jacoline Bouvy, Senior Scientific Adviser, talks about a growing area of interest for the Scientific ...
Posted by Michael Wonder on 27 Jul 2019
Stories of patient involvement impact in health technology assessments: a discussion paper
24 July 2019 - As more health technology assessment bodies seek to implement patient involvement, there is a desire to learn ...
Posted by Michael Wonder on 10 Jul 2019
New committee brings diverse patient, family, and caregiver voices to CADTH
10 July 2019 - Following a nationwide call for nominations, CADTH is pleased to announce the membership of its new ...
Posted by Michael Wonder on 01 Jul 2019
Ethical challenges related to patient involvement in health technology assessment
28 June 2019 - Including information and values from patients in HTA has the potential to improve both the process and ...
Posted by Michael Wonder on 28 Mar 2019
Keeping up the PACE at the Scottish Medicines Consortium
26 March 2019 - There are many ways that patient centricity could be delivered when doing a health technology assessment. ...
Posted by Michael Wonder on 14 Feb 2019
NICE provides first scientific advice on patient preference study design
14 February 2019 - The NICE Scientific Advice team, working with the Science Policy and Research team at NICE, has provided ...
Posted by Michael Wonder on 18 Jan 2019
Patient groups fail to declare financial interests during NICE assessments
16 January 2019 - Patients’ groups involved in assessing treatments for the NHS often fail to disclose their financial interests, ...
Posted by Michael Wonder on 07 Dec 2018
Proposal to list a new presentation of raltegravir and amend arrangements for raltegravir and posaconazole
7 December 2018 - PHARMAC is seeking feedback on a multi-product proposal with Merck Sharpe & Dohme. ...
Posted by Michael Wonder on 25 Aug 2018
Ensuring patient voices are heard: how patients can contribute to the CADTH Symposium
24 August 2018 - This webinar will outline the process for submitting abstracts and offer tips and ideas to increase the ...
Posted by Michael Wonder on 17 Aug 2018
Post-market review of the use of biologics in the treatment of severe chronic plaque psoriasis
17 August 2018 - The PBAC minutes pertaining to the draft review report for the post-market review of the use of ...
Posted by Michael Wonder on 12 Jul 2018
Are health apps good for your health? Have your say.
12 July 2018 - The Consumers Health Forum today introduces an innovative online mechanism to gauge community trust in health ...
Posted by Michael Wonder on 28 May 2018
Community voices important to PHARMAC
28 May 2018 - This year, PHARMAC is reviewing the way we seek and incorporate the consumer voice in our ...
Posted by Michael Wonder on 21 May 2018
August 2018 PBAC special meeting - invitation for submissions open and background paper available
21 May 2018 - PD-1 and PD-L1 checkpoint inhibitor immunotherapies: options for subsidy consideration for multiple cancer types. ...